APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Second Opinion

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

Selected research

Market Structure

Global Medical Second Opinion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchMedical Second Opinion Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Second Opinion Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medical Second Opinion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Second Opinion Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Second Opinion Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

The major players in global Medical Second Opinion market include HCA Hospitals, AXA PPP Healthcare, Royal London Group, etc. The top 3 players occupy about 20% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Hospitals is the main type, with a share about 45%. Cancer is the main application, which holds a share about 25%.

Report Includes

Read the full market overview

This report provides an overview of the global Medical Second Opinion market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Second Opinion and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Second Opinion revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Second Opinion market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Second Opinion Segment by Company

HCA Hospitals

AXA PPP Healthcare

Royal London Group

Helsana Group

Cleveland Clinic

Amradnet

Best Doctors Inc

Inova Care

Toranomon Hospital

Keio University Hospital

Johns Hopkins Medicine

Penn Medicine

Oncology International Pvt. Ltd.

GrandOpinion

London Pain Clinic

Mondial Assistance

Medisense

Medo Asia Sdn. Bhd.

Medical Second Opinion Segment by Type

Hospitals

Medical Second Opinion Providing Companies

Health Insurance Companies

Medical Second Opinion Segment by Application

Cancer

Diabetes

Cardiac Disorders

Neurological Disorders

Ocular Disorders

Others

Medical Second Opinion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Second Opinion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Second Opinion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Second Opinion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Second Opinion in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Second Opinion industry.

Chapter 3: Detailed analysis of Medical Second Opinion companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Second Opinionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Second Opinion Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Hospitals Table 3. Key Players of Medical Second Opinion Providing Companies Table 4. Key Players of Health Insurance Companies Table 4. Global Medical Second Opinion Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Table 6. Key Players of Diabetes Table 7. Key Players of Cardiac Disorders Table 8. Key Players of Neurological Disorders Table 9. Key Players of Ocular Disorders Table 10. Key Players of Others Table 11. Global Medical Second Opinion Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Medical Second Opinion Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Medical Second Opinion Market Share by Region (2021-2026) Table 14. Global Medical Second Opinion Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Medical Second Opinion Market Share by Region (2027-2032) Table 16. Medical Second Opinion Industry Trends Table 17. Medical Second Opinion Industry Drivers Table 18. Medical Second Opinion Industry Opportunities and Challenges Table 19. Medical Second Opinion Industry Restraints Table 20. Global Medical Second Opinion Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Medical Second Opinion Revenue Market Share by Company (2021-2026) Table 22. Global Medical Second Opinion Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Medical Second Opinion Key Company Head Office and Area Served Table 24. Global Medical Second Opinion Company, Product Type & Application Table 25. Global Medical Second Opinion Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Medical Second Opinion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Medical Second Opinion Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Medical Second Opinion Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Medical Second Opinion Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Medical Second Opinion Revenue Market Share by Type (2021-2026) Table 32. Global Medical Second Opinion Revenue Market Share by Type (2027-2032) Table 33. Global Medical Second Opinion Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Medical Second Opinion Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Medical Second Opinion Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Medical Second Opinion Revenue Market Share by Application (2021-2026) Table 37. Global Medical Second Opinion Revenue Market Share by Application (2027-2032) Table 38. HCA Hospitals Company Information Table 39. HCA Hospitals Business Overview Table 40. HCA Hospitals Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. HCA Hospitals Medical Second Opinion Product Portfolio Table 42. HCA Hospitals Recent Development Table 43. AXA PPP Healthcare Company Information Table 44. AXA PPP Healthcare Business Overview Table 45. AXA PPP Healthcare Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. AXA PPP Healthcare Medical Second Opinion Product Portfolio Table 47. AXA PPP Healthcare Recent Development Table 48. Royal London Group Company Information Table 49. Royal London Group Business Overview Table 50. Royal London Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Royal London Group Medical Second Opinion Product Portfolio Table 52. Royal London Group Recent Development Table 53. Helsana Group Company Information Table 54. Helsana Group Business Overview Table 55. Helsana Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Helsana Group Medical Second Opinion Product Portfolio Table 57. Helsana Group Recent Development Table 58. Cleveland Clinic Company Information Table 59. Cleveland Clinic Business Overview Table 60. Cleveland Clinic Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Cleveland Clinic Medical Second Opinion Product Portfolio Table 62. Cleveland Clinic Recent Development Table 63. Amradnet Company Information Table 64. Amradnet Business Overview Table 65. Amradnet Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Amradnet Medical Second Opinion Product Portfolio Table 67. Amradnet Recent Development Table 68. Best Doctors Inc Company Information Table 69. Best Doctors Inc Business Overview Table 70. Best Doctors Inc Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Best Doctors Inc Medical Second Opinion Product Portfolio Table 72. Best Doctors Inc Recent Development Table 73. Inova Care Company Information Table 74. Inova Care Business Overview Table 75. Inova Care Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Inova Care Medical Second Opinion Product Portfolio Table 77. Inova Care Recent Development Table 78. Toranomon Hospital Company Information Table 79. Toranomon Hospital Business Overview Table 80. Toranomon Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Toranomon Hospital Medical Second Opinion Product Portfolio Table 82. Toranomon Hospital Recent Development Table 83. Keio University Hospital Company Information Table 84. Keio University Hospital Business Overview Table 85. Keio University Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Keio University Hospital Medical Second Opinion Product Portfolio Table 87. Keio University Hospital Recent Development Table 88. Johns Hopkins Medicine Company Information Table 89. Johns Hopkins Medicine Business Overview Table 90. Johns Hopkins Medicine Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Johns Hopkins Medicine Medical Second Opinion Product Portfolio Table 92. Johns Hopkins Medicine Recent Development Table 93. Penn Medicine Company Information Table 94. Penn Medicine Business Overview Table 95. Penn Medicine Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Penn Medicine Medical Second Opinion Product Portfolio Table 97. Penn Medicine Recent Development Table 98. Oncology International Pvt. Ltd. Company Information Table 99. Oncology International Pvt. Ltd. Business Overview Table 100. Oncology International Pvt. Ltd. Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio Table 102. Oncology International Pvt. Ltd. Recent Development Table 103. GrandOpinion Company Information Table 104. GrandOpinion Business Overview Table 105. GrandOpinion Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. GrandOpinion Medical Second Opinion Product Portfolio Table 107. GrandOpinion Recent Development Table 108. London Pain Clinic Company Information Table 109. London Pain Clinic Business Overview Table 110. London Pain Clinic Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. London Pain Clinic Medical Second Opinion Product Portfolio Table 112. London Pain Clinic Recent Development Table 113. Mondial Assistance Company Information Table 114. Mondial Assistance Business Overview Table 115. Mondial Assistance Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 116. Mondial Assistance Medical Second Opinion Product Portfolio Table 117. Mondial Assistance Recent Development Table 118. Medisense Company Information Table 119. Medisense Business Overview Table 120. Medisense Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 121. Medisense Medical Second Opinion Product Portfolio Table 122. Medisense Recent Development Table 123. Medo Asia Sdn. Bhd. Company Information Table 124. Medo Asia Sdn. Bhd. Business Overview Table 125. Medo Asia Sdn. Bhd. Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 126. Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio Table 127. Medo Asia Sdn. Bhd. Recent Development Table 128. North America Medical Second Opinion Market Size by Type (2021-2026) & (US$ Million) Table 129. North America Medical Second Opinion Market Size by Type (2027-2032) & (US$ Million) Table 130. North America Medical Second Opinion Market Size by Application (2021-2026) & (US$ Million) Table 131. North America Medical Second Opinion Market Size by Application (2027-2032) & (US$ Million) Table 132. North America Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America Medical Second Opinion Market Size by Country (2021-2026) Table 134. North America Medical Second Opinion Market Size by Country (2027-2032) Table 135. Europe Medical Second Opinion Market Size by Type (2021-2026) & (US$ Million) Table 136. Europe Medical Second Opinion Market Size by Type (2027-2032) & (US$ Million) Table 137. Europe Medical Second Opinion Market Size by Application (2021-2026) & (US$ Million) Table 138. Europe Medical Second Opinion Market Size by Application (2027-2032) & (US$ Million) Table 139. Europe Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Medical Second Opinion Market Size by Country (2021-2026) Table 141. Europe Medical Second Opinion Market Size by Country (2027-2032) Table 142. China Medical Second Opinion Market Size by Type (2021-2026) & (US$ Million) Table 143. China Medical Second Opinion Market Size by Type (2027-2032) & (US$ Million) Table 144. China Medical Second Opinion Market Size by Application (2021-2026) & (US$ Million) Table 145. China Medical Second Opinion Market Size by Application (2027-2032) & (US$ Million) Table 146. Asia Medical Second Opinion Market Size by Type (2021-2026) & (US$ Million) Table 147. Asia Medical Second Opinion Market Size by Type (2027-2032) & (US$ Million) Table 148. Asia Medical Second Opinion Market Size by Application (2021-2026) & (US$ Million) Table 149. Asia Medical Second Opinion Market Size by Application (2027-2032) & (US$ Million) Table 150. Asia Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Medical Second Opinion Market Size by Country (2021-2026) Table 152. Asia Medical Second Opinion Market Size by Country (2027-2032) Table 153. South America, Middle East & Africa Medical Second Opinion Market Size by Type (2021-2026) & (US$ Million) Table 154. South America, Middle East & Africa Medical Second Opinion Market Size by Type (2027-2032) & (US$ Million) Table 155. South America, Middle East & Africa Medical Second Opinion Market Size by Application (2021-2026) & (US$ Million) Table 156. South America, Middle East & Africa Medical Second Opinion Market Size by Application (2027-2032) & (US$ Million) Table 157. South America, Middle East & Africa Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. South America, Middle East & Africa Medical Second Opinion Market Size by Country (2021-2026) Table 159. South America, Middle East & Africa Medical Second Opinion Market Size by Country (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Medical Second Opinion Product Image Figure 2. Global Medical Second Opinion Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Medical Second Opinion Market Share by Type: 2025 VS 2032 Figure 4. Hospitals Image Figure 5. Medical Second Opinion Providing Companies Image Figure 6. Health Insurance Companies Image Figure 7. Global Medical Second Opinion Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Medical Second Opinion Market Share by Application: 2025 VS 2032 Figure 9. Cancer Image Figure 10. Diabetes Image Figure 11. Cardiac Disorders Image Figure 12. Neurological Disorders Image Figure 13. Ocular Disorders Image Figure 14. Others Image Figure 15. Global Medical Second Opinion Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 17. Global Medical Second Opinion Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Medical Second Opinion Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Medical Second Opinion Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Medical Second Opinion Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Medical Second Opinion Revenue Market Share by Type (2021-2032) Figure 24. Global Medical Second Opinion Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Medical Second Opinion Revenue Market Share by Application (2021-2032) Figure 26. North America Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 27. North America Medical Second Opinion Market Share by Type (2021-2032) Figure 28. North America Medical Second Opinion Market Share by Application (2021-2032) Figure 29. North America Medical Second Opinion Market Share by Country (2021-2032) Figure 30. United States Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 31. Canada Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 33. Europe Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 34. Europe Medical Second Opinion Market Share by Type (2021-2032) Figure 35. Europe Medical Second Opinion Market Share by Application (2021-2032) Figure 36. Europe Medical Second Opinion Market Share by Country (2021-2032) Figure 37. Germany Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 38. France Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 40. Italy Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 41. Russia Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 43. China Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 44. China Medical Second Opinion Market Share by Type (2021-2032) Figure 45. China Medical Second Opinion Market Share by Application (2021-2032) Figure 46. Asia Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 47. Asia Medical Second Opinion Market Share by Type (2021-2032) Figure 48. Asia Medical Second Opinion Market Share by Application (2021-2032) Figure 49. Asia Medical Second Opinion Market Share by Country (2021-2032) Figure 50. Japan Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 54. India Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 55. Australia Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Medical Second Opinion Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Medical Second Opinion Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Medical Second Opinion Market Share by Country (2021-2032) Figure 60. Brazil Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 65. UAE Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 67. Chile Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Hospitals
  • Medical Second Opinion Providing Companies
  • Health Insurance Companies
Applications
  • Cancer
  • Diabetes
  • Cardiac Disorders
  • Neurological Disorders
  • Ocular Disorders
  • Others
Companies covered
  • HCA Hospitals
  • AXA PPP Healthcare
  • Royal London Group
  • Helsana Group
  • Cleveland Clinic
  • Amradnet
  • Best Doctors Inc
  • Inova Care
  • Toranomon Hospital
  • Keio University Hospital
  • Johns Hopkins Medicine
  • Penn Medicine
  • Oncology International Pvt. Ltd.
  • GrandOpinion
  • London Pain Clinic
  • Mondial Assistance
  • Medisense
  • Medo Asia Sdn. Bhd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Medical Second Opinion Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Hospitals
  5. 1.2.3 Medical Second Opinion Providing Companies
  6. 1.2.4 Health Insurance Companies
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Medical Second Opinion Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Diabetes
  11. 1.3.4 Cardiac Disorders
  12. 1.3.5 Neurological Disorders
  13. 1.3.6 Ocular Disorders
  14. 1.3.7 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Medical Second Opinion Growth Trends by Region
  17. 1.5.1 Global Medical Second Opinion Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Medical Second Opinion Market Size by Region (2021-2026)
  19. 1.5.3 Medical Second Opinion Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Medical Second Opinion Market Dynamics
  1. 2.1 Medical Second Opinion Industry Trends
  2. 2.2 Medical Second Opinion Industry Drivers
  3. 2.3 Medical Second Opinion Industry Opportunities and Challenges
  4. 2.4 Medical Second Opinion Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Medical Second Opinion Revenue by Company (2021-2026)
  2. 3.2 Global Medical Second Opinion Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Medical Second Opinion Key Company Head office and Area Served
  4. 3.4 Global Medical Second Opinion Company, Product Type & Application
  5. 3.5 Global Medical Second Opinion Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Medical Second Opinion Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Medical Second Opinion Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Medical Second Opinion Tier 1, Tier 2, and Tier 3
4 Medical Second Opinion Market by Type
  1. 4.1 Global Medical Second Opinion Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Medical Second Opinion Market Size by Type (2021-2032)
  3. 4.3 Global Medical Second Opinion Market Size Share by Type (2021-2032)
5 Medical Second Opinion Market by Application
  1. 5.1 Global Medical Second Opinion Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Second Opinion Market Size by Application (2021-2032)
  3. 5.3 Global Medical Second Opinion Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 HCA Hospitals
  2. 6.1.1 HCA Hospitals Company Information
  3. 6.1.2 HCA Hospitals Business Overview
  4. 6.1.3 HCA Hospitals Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 HCA Hospitals Medical Second Opinion Product Portfolio
  6. 6.1.5 HCA Hospitals Recent Developments
  7. 6.2 AXA PPP Healthcare
  8. 6.2.1 AXA PPP Healthcare Company Information
  9. 6.2.2 AXA PPP Healthcare Business Overview
  10. 6.2.3 AXA PPP Healthcare Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 AXA PPP Healthcare Medical Second Opinion Product Portfolio
  12. 6.2.5 AXA PPP Healthcare Recent Developments
  13. 6.3 Royal London Group
  14. 6.3.1 Royal London Group Company Information
  15. 6.3.2 Royal London Group Business Overview
  16. 6.3.3 Royal London Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Royal London Group Medical Second Opinion Product Portfolio
  18. 6.3.5 Royal London Group Recent Developments
  19. 6.4 Helsana Group
  20. 6.4.1 Helsana Group Company Information
  21. 6.4.2 Helsana Group Business Overview
  22. 6.4.3 Helsana Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Helsana Group Medical Second Opinion Product Portfolio
  24. 6.4.5 Helsana Group Recent Developments
  25. 6.5 Cleveland Clinic
  26. 6.5.1 Cleveland Clinic Company Information
  27. 6.5.2 Cleveland Clinic Business Overview
  28. 6.5.3 Cleveland Clinic Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Cleveland Clinic Medical Second Opinion Product Portfolio
  30. 6.5.5 Cleveland Clinic Recent Developments
  31. 6.6 Amradnet
  32. 6.6.1 Amradnet Company Information
  33. 6.6.2 Amradnet Business Overview
  34. 6.6.3 Amradnet Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Amradnet Medical Second Opinion Product Portfolio
  36. 6.6.5 Amradnet Recent Developments
  37. 6.7 Best Doctors Inc
  38. 6.7.1 Best Doctors Inc Company Information
  39. 6.7.2 Best Doctors Inc Business Overview
  40. 6.7.3 Best Doctors Inc Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Best Doctors Inc Medical Second Opinion Product Portfolio
  42. 6.7.5 Best Doctors Inc Recent Developments
  43. 6.8 Inova Care
  44. 6.8.1 Inova Care Company Information
  45. 6.8.2 Inova Care Business Overview
  46. 6.8.3 Inova Care Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Inova Care Medical Second Opinion Product Portfolio
  48. 6.8.5 Inova Care Recent Developments
  49. 6.9 Toranomon Hospital
  50. 6.9.1 Toranomon Hospital Company Information
  51. 6.9.2 Toranomon Hospital Business Overview
  52. 6.9.3 Toranomon Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Toranomon Hospital Medical Second Opinion Product Portfolio
  54. 6.9.5 Toranomon Hospital Recent Developments
  55. 6.10 Keio University Hospital
  56. 6.10.1 Keio University Hospital Company Information
  57. 6.10.2 Keio University Hospital Business Overview
  58. 6.10.3 Keio University Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Keio University Hospital Medical Second Opinion Product Portfolio
  60. 6.10.5 Keio University Hospital Recent Developments
  61. 6.11 Johns Hopkins Medicine
  62. 6.11.1 Johns Hopkins Medicine Company Information
  63. 6.11.2 Johns Hopkins Medicine Business Overview
  64. 6.11.3 Johns Hopkins Medicine Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Johns Hopkins Medicine Medical Second Opinion Product Portfolio
  66. 6.11.5 Johns Hopkins Medicine Recent Developments
  67. 6.12 Penn Medicine
  68. 6.12.1 Penn Medicine Company Information
  69. 6.12.2 Penn Medicine Business Overview
  70. 6.12.3 Penn Medicine Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Penn Medicine Medical Second Opinion Product Portfolio
  72. 6.12.5 Penn Medicine Recent Developments
  73. 6.13 Oncology International Pvt. Ltd.
  74. 6.13.1 Oncology International Pvt. Ltd. Company Information
  75. 6.13.2 Oncology International Pvt. Ltd. Business Overview
  76. 6.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio
  78. 6.13.5 Oncology International Pvt. Ltd. Recent Developments
  79. 6.14 GrandOpinion
  80. 6.14.1 GrandOpinion Company Information
  81. 6.14.2 GrandOpinion Business Overview
  82. 6.14.3 GrandOpinion Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 GrandOpinion Medical Second Opinion Product Portfolio
  84. 6.14.5 GrandOpinion Recent Developments
  85. 6.15 London Pain Clinic
  86. 6.15.1 London Pain Clinic Company Information
  87. 6.15.2 London Pain Clinic Business Overview
  88. 6.15.3 London Pain Clinic Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 London Pain Clinic Medical Second Opinion Product Portfolio
  90. 6.15.5 London Pain Clinic Recent Developments
  91. 6.16 Mondial Assistance
  92. 6.16.1 Mondial Assistance Company Information
  93. 6.16.2 Mondial Assistance Business Overview
  94. 6.16.3 Mondial Assistance Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Mondial Assistance Medical Second Opinion Product Portfolio
  96. 6.16.5 Mondial Assistance Recent Developments
  97. 6.17 Medisense
  98. 6.17.1 Medisense Company Information
  99. 6.17.2 Medisense Business Overview
  100. 6.17.3 Medisense Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Medisense Medical Second Opinion Product Portfolio
  102. 6.17.5 Medisense Recent Developments
  103. 6.18 Medo Asia Sdn. Bhd.
  104. 6.18.1 Medo Asia Sdn. Bhd. Company Information
  105. 6.18.2 Medo Asia Sdn. Bhd. Business Overview
  106. 6.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio
  108. 6.18.5 Medo Asia Sdn. Bhd. Recent Developments
7 North America
  1. 7.1 North America Medical Second Opinion Market Size (2021-2032)
  2. 7.2 North America Medical Second Opinion Market Size by Type
  3. 7.2.1 North America Medical Second Opinion Market Size by Type (2021-2026)
  4. 7.2.2 North America Medical Second Opinion Market Size by Type (2027-2032)
  5. 7.2.3 North America Medical Second Opinion Market Share by Type (2021-2032)
  6. 7.3 North America Medical Second Opinion Market Size by Application
  7. 7.3.1 North America Medical Second Opinion Market Size by Application (2021-2026)
  8. 7.3.2 North America Medical Second Opinion Market Size by Application (2027-2032)
  9. 7.3.3 North America Medical Second Opinion Market Share by Application (2021-2032)
  10. 7.4 North America Medical Second Opinion Market Size by Country
  11. 7.4.1 North America Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Medical Second Opinion Market Size by Country (2021-2026)
  13. 7.4.3 North America Medical Second Opinion Market Size by Country (2027-2032)
  14. 7.4.4 North America Medical Second Opinion Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Medical Second Opinion Market Size (2021-2032)
  2. 8.2 Europe Medical Second Opinion Market Size by Type
  3. 8.2.1 Europe Medical Second Opinion Market Size by Type (2021-2026)
  4. 8.2.2 Europe Medical Second Opinion Market Size by Type (2027-2032)
  5. 8.2.3 Europe Medical Second Opinion Market Share by Type (2021-2032)
  6. 8.3 Europe Medical Second Opinion Market Size by Application
  7. 8.3.1 Europe Medical Second Opinion Market Size by Application (2021-2026)
  8. 8.3.2 Europe Medical Second Opinion Market Size by Application (2027-2032)
  9. 8.3.3 Europe Medical Second Opinion Market Share by Application (2021-2032)
  10. 8.4 Europe Medical Second Opinion Market Size by Country
  11. 8.4.1 Europe Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Medical Second Opinion Market Size by Country (2021-2026)
  13. 8.4.3 Europe Medical Second Opinion Market Size by Country (2027-2032)
  14. 8.4.4 Europe Medical Second Opinion Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Medical Second Opinion Market Size (2021-2032)
  2. 9.2 China Medical Second Opinion Market Size by Type
  3. 9.2.1 China Medical Second Opinion Market Size by Type (2021-2026)
  4. 9.2.2 China Medical Second Opinion Market Size by Type (2027-2032)
  5. 9.2.3 China Medical Second Opinion Market Share by Type (2021-2032)
  6. 9.3 China Medical Second Opinion Market Size by Application
  7. 9.3.1 China Medical Second Opinion Market Size by Application (2021-2026)
  8. 9.3.2 China Medical Second Opinion Market Size by Application (2027-2032)
  9. 9.3.3 China Medical Second Opinion Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Medical Second Opinion Market Size (2021-2032)
  2. 10.2 Asia Medical Second Opinion Market Size by Type
  3. 10.2.1 Asia Medical Second Opinion Market Size by Type (2021-2026)
  4. 10.2.2 Asia Medical Second Opinion Market Size by Type (2027-2032)
  5. 10.2.3 Asia Medical Second Opinion Market Share by Type (2021-2032)
  6. 10.3 Asia Medical Second Opinion Market Size by Application
  7. 10.3.1 Asia Medical Second Opinion Market Size by Application (2021-2026)
  8. 10.3.2 Asia Medical Second Opinion Market Size by Application (2027-2032)
  9. 10.3.3 Asia Medical Second Opinion Market Share by Application (2021-2032)
  10. 10.4 Asia Medical Second Opinion Market Size by Country
  11. 10.4.1 Asia Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Medical Second Opinion Market Size by Country (2021-2026)
  13. 10.4.3 Asia Medical Second Opinion Market Size by Country (2027-2032)
  14. 10.4.4 Asia Medical Second Opinion Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Medical Second Opinion Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Medical Second Opinion Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Medical Second Opinion Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Medical Second Opinion Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Medical Second Opinion Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Medical Second Opinion Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Medical Second Opinion Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Medical Second Opinion Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Medical Second Opinion Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Medical Second Opinion Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Medical Second Opinion Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Medical Second Opinion Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Medical Second Opinion Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Medical Second Opinion Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst